These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25134024)

  • 41. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Within-person associations between psychological and contextual factors and lapse incidence in smokers attempting to quit: A systematic review and meta-analysis of ecological momentary assessment studies.
    Perski O; Kwasnicka D; Kale D; Schneider V; Szinay D; Ten Hoor G; Asare BY; Verboon P; Powell D; Naughton F; Keller J
    Addiction; 2023 Jul; 118(7):1216-1231. PubMed ID: 36807443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.
    Saxon AJ; Baer JS; Davis TM; Sloan KL; Malte CA; Fitzgibbons K; Kivlahan DR
    Nicotine Tob Res; 2003 Aug; 5(4):589-96. PubMed ID: 12959797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion.
    Wileyto EP; Patterson F; Niaura R; Epstein LH; Brown RA; Audrain-McGovern J; Hawk LW; Lerman C
    Nicotine Tob Res; 2005 Apr; 7(2):257-68. PubMed ID: 16036283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
    McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB
    Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective analysis of early lapse to drinking and smoking among individuals in concurrent alcohol and tobacco treatment.
    Holt LJ; Litt MD; Cooney NL
    Psychol Addict Behav; 2012 Sep; 26(3):561-72. PubMed ID: 22023022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
    Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
    Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
    BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Affective and Situational Precipitants of Smoking Lapses Among Adolescents.
    Treloar Padovano H; Merrill JE; Colby SM; Kahler CW; Gwaltney CJ
    Nicotine Tob Res; 2020 Apr; 22(4):492-497. PubMed ID: 30624745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective examination of distress tolerance and early smoking lapse in adult self-quitters.
    Brown RA; Lejuez CW; Strong DR; Kahler CW; Zvolensky MJ; Carpenter LL; Niaura R; Price LH
    Nicotine Tob Res; 2009 May; 11(5):493-502. PubMed ID: 19372572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Smoking cessation abstinence goal in treatment-seeking smokers.
    Hall SM; Shi Y; Humfleet GL; Muñoz RF; Reus VI; Prochaska JJ
    Addict Behav; 2015 Mar; 42():148-53. PubMed ID: 25462664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pain Status as a Predictor of Smoking Cessation Initiation, Lapse, and Relapse.
    Ditre JW; Heckman BW; LaRowe LR; Powers JM
    Nicotine Tob Res; 2021 Jan; 23(1):186-194. PubMed ID: 32594124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. If at first you don't succeed: characterization of smokers with late smoking abstinence onset.
    Leyro TM; Hendricks PS; Hall SM
    Addict Behav; 2015 Jun; 45():34-8. PubMed ID: 25637886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors.
    Powell J; Dawkins L; West R; Powell J; Pickering A
    Psychopharmacology (Berl); 2010 Dec; 212(4):537-49. PubMed ID: 20703450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.
    Anthenelli RM; Gaffney M; Benowitz NL; West R; McRae T; Russ C; Lawrence D; St Aubin L; Krishen A; Evins AE
    J Gen Intern Med; 2019 Jun; 34(6):862-870. PubMed ID: 30847828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multicomponent smoking cessation treatment including mobile contingency management in homeless veterans.
    Carpenter VL; Hertzberg JS; Kirby AC; Calhoun PS; Moore SD; Dennis MF; Dennis PA; Dedert EA; Hair LP; Beckham JC
    J Clin Psychiatry; 2015 Jul; 76(7):959-64. PubMed ID: 25699616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms linking mindfulness and early smoking abstinence: An ecological momentary assessment study.
    Spears CA; Li L; Wu C; Vinci C; Heppner WL; Hoover DS; Lam C; Wetter DW
    Psychol Addict Behav; 2019 May; 33(3):197-207. PubMed ID: 30829517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time-varying processes involved in smoking lapse in a randomized trial of smoking cessation therapies.
    Vasilenko SA; Piper ME; Lanza ST; Liu X; Yang J; Li R
    Nicotine Tob Res; 2014 May; 16 Suppl 2(Suppl 2):S135-43. PubMed ID: 24711627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.